Learn about the procedure costs risks and recovery of a bone marrow transplant.
Multiple myeloma stem cell transplant recovery.
The standard of care for fit multiple myeloma patients is to receive high dose chemotherapy hdt with autologous stem cell rescue otherwise known as autologous stem cell transplant asct after completion of induction therapy.
There can be a long period of dormancy that could.
In allogeneic transplantation stem cells are given by a donor most commonly a brother or sister.
For an autologous stem cell transplant the.
People who have autologous or allogeneic transplants first receive high dose chemotherapy to kill the cancer cells.
See drug therapy for multiple myeloma stem cell transplants sct can be autologous or allogeneic.
In some cases a bone marrow or stem cell transplant is an option.
The 2 most common problems after this type of transplant are.
Recovery after a donor transplant takes much longer.
Stem cell transplant is commonly used to treat multiple myeloma.
Stem cell transplants have become important weapons in the fight against certain blood cancers such as multiple myeloma non hodgkin s lymphoma hodgkin lymphoma and leukemia a stem cell.
Charlie rider had a stem cell transplant at dana farber as young boy.
How you can help.
And the risk of side effects or complications is higher.
The risk of infection is higher and lasts longer than in transplants using your own stem cells.
Diagnosed with multiple myeloma in august 2010 she had a stem cell transplant in march 2011 and as of september 2013 was on post transplant maintenance bio therapy at dana farber brigham and women s cancer center.
The recovery of polyclonal ig was defined as normalization of all values of serum igg iga and igm 1 year after asct.
One viable treatment option for multiple myeloma patients is a stem cell transplant.
Autologous stem cell transplantation is more common for multiple myeloma but either type of transplant can be used.
Multiple myeloma isn t considered curable but symptoms wax and wane.
We retrospectively analyzed multiple myeloma mm patients who underwent autologous stem cell transplantation asct without maintenance therapy to assess the impact of recovery of normal immunoglobulin ig on clinical outcomes.